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Background: Cognitive impairments in bipolar disorder (BD) such as memory deficits 
are associated with poor functional outcomes and it has been suggested that the brain-
derived neurotrophic factor (BDNF) Val66Met polymorphism contributes to individual 
variability in memory function in BD. The current study investigated the relationship 
between the BDNF Val66Met polymorphism, neural activity during a picture-encoding 
task, and subsequent memory recall.
Methods: A total of 70 patients with BD grouped according to genotype [ValVal or Met 
carriers (MetVal/MetMet)] underwent fMRI while performing a picture-encoding task. 
Memory for the encoded pictures was tested with a subsequent free recall memory task.
Results: There was no difference between the ValVal homozygotes and Met carriers in 
the involvement of hypothesized memory encoding regions i.e. hippocampus and dorsal 
prefrontal cortex (dPFC). However, an exploratory whole-brain analysis showed greater 
encoding-related lateral occipital cortex activity in Met carriers. Behaviorally, Met carriers 
also showed better free recall of the encoded pictures.
Conclusions: We found no effect of the BDNF genotype on encoding-related hippocampal 
and dPFC activity in BD, although Met carriers showed superior memory performance 
after the scan, which could be related to more efficient perceptual processing during 
encoding.
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BaCKgROUND
Cognitive impairments in bipolar disorder (BD) are associated with 
reduced functional capacity and poor prognosis (1). Specifically, 
patients’ verbal memory and executive function are among the 
strongest predictors for vocational capacity (2). The pattern of 
cognitive impairment in BD is heterogeneous, as some patients 
remain cognitively intact while up to 60% present with selective or 
global impairments (1). It is likely that genetic factors play a role 
in this heterogeneity, but the contribution of risk genotypes to the 
cognitive impairments in BD is poorly understood. It is important 
to gain a better understanding of these relationships and the factors 
that contribute to the cognitive heterogeneity seen in BD in order to 
offer personalized treatments and identify new therapeutic targets.
Several candidate vulnerability marker genes believed to 
confer risk of cognitive deficits in psychiatric disorders have been 
explored using cognitive assessments and imaging genetics (3). 
These include the Val66Met single nucleotide polymorphism in 
the gene encoding brain-derived neurotrophic factor (BDNF) 
and its relationship with memory function. In the Val66Met 
polymorphism, a valine to methionine substitution at codon 66 
results in a switch from guanine to adenine at position 196 in 
the pro-region of the BDNF gene, leading to reduced activity-
dependent BDNF secretion and potential associated changes in 
hippocampal functions such as episodic memory (4, 5).
There is some evidence suggesting that the Val66Met 
polymorphism affects cognition and neural processing, although 
findings from existing studies are mixed (6–10). A systematic review 
of studies using clinical and healthy populations found that 23 of 
63 studies showed a significant relationship between memory and 
Val66Met carrier status (11). For example, Egan et al. (10) found 
reduced free recall memory for an auditory short story in Met 
carriers, which is known to rely on the hippocampus, although 
this effect of genotype was not present on a second measure 
of free recall [California Verbal Learning Test (CVLT)]. Some 
studies have also reported relationships between Val66Met and 
aspects of memory that are known to be less dependent of the 
hippocampus such as recognition memory (12, 13). However, in 
a study using a similar task to the task used in the current study, 
Dodds et al. (6) presented healthy participants with scene pictures 
during encoding and asked participants to make indoor/outdoor 
judgments of the pictures as they were presented. Subsequently, 
participants completed a recognition memory test indicating 
whether the presented pictures were old or new. This study found 
no differences in memory performance or neural activity during 
encoding between BDNF Val66Met genotypes among these healthy 
individuals. However, subsequent studies using similar paradigms 
have found both reduced (9) and increased (8) MTL activity during 
memory encoding, and hence, inconsistencies in studies with 
healthy participants remain.
Given the albeit mixed evidence for impact of BDNF 
genotype on memory performance and related neural processing 
across healthy and psychiatric populations, it is pertinent to 
consider that BDNF genotype might play a role in the cognitive 
heterogeneity seen in BD but only few studies have investigated 
the relationship between memory and Val66Met genotype in BD. 
One study showed that Met carriers with BD displayed reduced 
verbal memory performance (and smaller hippocampal volumes) 
compared to both healthy and depressed Met carriers, suggesting 
a specific disadvantage for Met carrier BD patients on memory 
function (14). Another study using a more general screening for 
cognitive function including memory did not find an association 
with Val66Met status (15). To our knowledge, no studies have 
investigated the neural underpinnings of the association between 
BDNF Val66Met genotype and memory performance in BD, 
which may provide a more sensitive measure of the relationship 
between genotype, memory function, and neural mechanisms.
In this study, we investigated the effects of BDNF genotype 
on encoding-related hippocampal and prefrontal cortex (PFC) 
activity and memory retrieval in a strategic picture-encoding 
task in 70 patients with BD in full or partial remission. We used 
a picture encoding task identical to Dodds et al. (6) but used a 
free recall memory task to assess memory performance instead 
of a recognition task. Free recall of complex scenes relies heavily 
on the hippocampus (16) and also the PFC (17, 18) and these 
neural mechanisms appear to be specific for free recall over for 
instance item memory (19–21). Further, studies have indicated 
a possible advantage of Met carriers in terms of PFC function 
and working memory (22–24). For instance, one study showed 
that over-expression of BDNF in mice resulted in decreased 
working memory function (23). Also, altered PFC activity has 
been associated with cognitive deficits in BD (25, 26). Hence, 
we hypothesized that i) Met carriers would show reduced 
hippocampal and/or increased dorsal PFC (dPFC) activity 
during picture encoding and ii) this altered activity would be 
associated with impaired free recall for the encoded pictures.
MaTERIals aND METHODs
Participants
Seventy BD patients in partial or full remission were included in 
the study. Baseline data for the patients was obtained from patients’ 
participation in two randomized intervention studies investigating 
cognitive function in BD (27, 28). Participants were between 18 
and 65 years of age (mean ± SD; 37 ± 10) and had normal or 
corrected-to-normal vision. All participants were screened with 
Schedules for Clinical Assessment in Neuropsychiatry (SCAN) 
to confirm diagnosis of BD. Participants were also rated on the 
Hamilton Depression Rating Scale [HDRS-17; (29)] and Young 
Mania Scale [YMRS; (30)] to confirm that they were in partial or 
full remission (HDRS and YMRS scores ≤14). The original studies 
were approved by the local ethics committee, Danish Data Agency, 
and Danish Medicines Agency, and written consent was obtained 
from all participants prior to beginning of the study. For further 
details on the recruitment and screening processes, please see 
previous studies (27, 28).
genotyping
Genomic DNA was extracted from blood samples with the 
Maxwell Blood DNA purification kit (Promega, Madison, 
WI, USA) in accordance with the manufacturer’s protocol 
and the samples were genotyped using the Illumina Infinium 
PsychArrayBeadChip (Illumina, San Diego, CA, USA).
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Magnetic Resonance Imaging
fMRI data was collected at the Danish Research Centre for Magnetic 
Resonance with an eight-channel head coil on a 3T Siemens 
Trio MR scanner (Siemens, Erlangen, Germany). Blood oxygen 
level-dependent T2*-weighted functional images were acquired 
using echo-planar imaging (EPI) with the following parameters: 
repetition time (TR), 2490 ms; echo time, 30 ms; slice thickness, 3 
mm; field of view (FOV), 192 × 192 mm using a 64 × 64 grid, flip 
angle 20°. A total of 117 volumes were acquired in a single fMRI 
session and each volume consisted of 42 slices. A field-map was 
recorded to allow distortion correction of the acquired EPI images. 
Participants also underwent a high-resolution structural scan where 
a T1-weighted 3D structural image was acquired to co-register with 
the functional images, with the following parameters: TI = 800, 
TE = 3.93, TR = 1540 ms, flip angle 9°, 1 × 1 × 1 mm voxel size, 
256×256 FOV, and 192 slices.
fMRI Data analysis
Pre-Processing
Pre-processing was carried out with the fMRI Expert Analysis 
Tool (FEAT; version 6.0) in FMRIB’s software library (FSL; www.
fmrib.ox.ac.uk/fsl). Standard pre-processing steps included non-
brain removal, realignment, correction for B0 field distortions, 
slice time correction, and spatial normalization of functional 
and structural images to a Montreal Neurologic Institute (MNI) 
template. The normalized functional images were spatially 
smoothed using an isotropic Gaussian smoothing kernel with a 
full width at half maximum (FWHM) of 5 mm. The time series in 
each session was high pass filtered (to max. 0.008 Hz).
Statistical Analysis
At the first level, picture encoding and rest events were 
modelled as boxcar functions and convolved with a canonical 
hemodynamic response function. A picture encoding BOLD 
contrast was computed by subtracting non-encoding periods 
from the picture encoding events.
At group level, we assessed differences in the picture-encoding 
contrast task between the two genotype groups. The group-
level statistical estimation was carried out using nonparametric 
permutation tests with the FSL Randomise tool (http://www.fmrib.
ox.ac.uk/fsl/randomise/index.html, 31) using default settings and 
5000 permutations. This method was used as it has been shown 
that permutation testing produces nominal results for clusterwise 
inference, while parametric statistical methods failed to do so (32). 
ValVal and Met carrier genotype groups were contrasted for each 
of the pre-determined regions of interest (ROIs). The ROIs were 
constructed on the MNI template and included bilateral hippocampi 
and the dPFC. The hippocampal ROI was anatomically defined, 
while the dPFC ROI was a spherical ROI based on a previous paper 
investigating dPFC activity during encoding and subsequent free 
recall (33) (Figure 1). The bilateral hippocampus was defined using 
cortical maps thresholded at 30% provided by the Harvard-Oxford 
cortical structure atlas implemented in FSLView (34). In addition 
to these ROI analyses, we conducted an exploratory whole-brain 
analysis applying a brain mask to investigate whether genotype 
groups’ encoding-related activity differed in any other (unforeseen) 
regions. For analyses at the group level, demographic variables 
including age, sex, years of education, and clinical variables (HDRS 
and YMRS) were modelled as regressors of no interest. The resulting 
data were assessed using Threshold-Free Cluster Enhancement 
(TFCE) to identify potential clusters (35).
Finally, we extracted the encoding-related BOLD signal 
change from the predefined ROIs and any additional regions 
showing differential response between genotype groups and 
correlated these values with participants subsequent recall score.
Picture Encoding and Retrieval Task
Stimuli pictures consisted of images of complex scenes collected 
from the International Affective Picture System [IAPS; (36)]. 
Several studies have demonstrated that encoding of such complex 
images is related to hippocampal activity (9, 37). All images were 
matched for valence, arousal, and complexity. Participants received 
instructions on the screen prior to the beginning of the task. 
During fMRI, participants viewed six 24-s picture blocks, each 
block consisting of six pictures. Each picture was presented on the 
screen for 3 s followed by an inter-stimulus interval (ISI) of 1 s in 
a pseudo-randomized order. Each picture block was followed by a 
short rest in which participants saw a fixation cross presented in 
the middle of the screen for 24 s. The total duration of the task was 
approximately 5 min. Participants were instructed to pay careful 
attention to the presented pictures, as they would be required to 
complete a subsequent memory task. Hence, the task comprised 
a strategic memory-encoding component. Participants were also 
instructed to make indoor-outdoor judgments for each picture, 
ensuring that participants paid attention to the task. Each picture 
block contained an equal number of indoor and outdoor scenes. 
Immediately following the scanning session, participants 
completed a free recall test of the pictures, in which participants 
FIgURE 1 | Visualization of the dPFC (above) and hippocampal (below) ROIs.
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were instructed to tell the experimenter about as many pictures 
they could remember and describe each picture in detail. One 
point was awarded for each remembered picture, yielding a total 
free recall score.
statistical analysis
Analyses of behavioral data and extracted mean percent signal 
change from the identified clusters in the FSL Randomise analysis 
were performed using SPSS (version 22; IBM Corporation).
As only a small number (N = 4) of participants carried the 
MetMet genotype, ValMet and MetMet carriers were pooled 
together in a Met-carrier (MetCar) group (N = 26) and compared 
to ValVal homozygotes (N = 43). Performance on the picture 
memory task was calculated as the number of correctly recalled 
images on the free recall test. For each participant, a raw score 
was calculated with a score of 1 being given for each remembered 
picture. The total number of false positives was also recorded. 
ValVal vs MetCar genotypes were compared for demographic 
and clinical variables and performance on memory tests using 
independent samples t-tests (two-tailed) and χ2. The relationship 
between neural activity in ROIs/significant clusters and memory 
performance was assessed with Pearson’s correlations and Fisher’s 
r to z transformation. Likewise, the relationship between clinical 
measures, age, years of education, memory recall, and neural 
activity was assessed with Pearson’s correlations. Interaction 
effects between genotype and total number of medications on 
memory recall and encoding-related activity was assessed with 
a univariate ANOVA.
For all tests, it was ensured that assumptions were met, and where 
assumptions were violated, data were either square-root transformed 
to fit a Gaussian distribution or analyzed with non-parametric tests 
(Mann-Whitney U). The alpha-level was set at P = 0.05.
REsUlTs
Of the 70 participants recruited for the study, two participants had 
missing behavioral data and were omitted from fMRI analyses, 
yielding N = 68 subjects (ValVal: N = 42; ValMet/MetMet: N = 
26) for analysis. There were no differences between the ValVal 
and the ValMet/MetMet genotype groups in demographic or 
clinical variables including age, years in education, age at onset, 
illness duration, number of hospitalisations, mood symptoms, or 
medication status (P > 0.05; Table 1).
Functional MRI analysis
Main Effect of Task
To confirm that the task was associated with the expected activity 
in visual areas and the hypothesized ROIs, we carried out a non-
parametric one-sample t-test across all subjects showing that 
picture encoding was associated with activity in a large network 
of brain regions, including the dorsal PFC, occipital, parietal, and 
temporal regions (see Figure 2; network shown in green). Across 
all participants, picture encoding vs. baseline was also associated 
with increased activity in the predefined ROIs: the bilateral 
hippocampi and the dPFC (TFCE corrected P < 0.05).
Effect of Genotype
In contrast to our hypothesis, there were no significant effects 
of genotype on encoding-related neural activity in the bilateral 
hippocampus, or in the dPFC at P = 0.05 (TFCE) in the ROI analyses. 
An exploratory whole-brain analysis showed that Met carriers 
displayed greater activity in a cluster located to the lateral occipital 
(LO) cortex compared to participants with the ValVal genotype 
(peak coordinate: x = –58 y = –66, z = –8; Table 2; Figure 2).
Relationship Between Neural Activity and 
Memory Performance
Across all subjects, there was no statistically significant correlation 
between hippocampal activity (mean % signal change) and 
TaBlE 1 | Means (SD) for demographic and clinical variables, picture memory 
task performance, and significance levels for differences between the ValVal and 
the ValMet/MetMet groups in remitted patients with bipolar disorder.
Variable genotype P-value
ValVal 
(N = 43)
ValMet/MetMet 
(N = 27)
Age, mean (SD) 36.2 (10.3) 37.6 (10.7) 0.58
Years of education, mean (SD) 15.5 (3.2) 15.0 (3.4) 0.51
Age at onset 20.0 (9.3) 21.15 (9.6) 0.67
BD type, no type 1 (%) 18 (48.6) 13 (61.9) 0.33
Illness duration, mean (SD) 16.8 (8.9) 16.8 (11.4) 0.98
No of depressive episodes, 
mean (SD)
6.1 (5.9) 7.3 (8.7) 0.55
No of manic episodes mean 
(SD)
8.7 (8.5) 7.4 (10.8) 0.61
No of hospitalisations, mean 
(SD)
2.7(0.8) 2.7 (0.8) 0.78
Gender, no women (%) 60.0 56.5 0.99
HDRS-17 baseline, mean (SD) 7.6 (5.1) 7.9 (4.8) 0.75
YMRS baseline, mean (SD) 2.1 (2.4) 2.5 (2.4) 0.33
Picture Memory score, mean 
(SD)
8.0 (5.3) 10.3 (5.0) 0.05
Medication
Lithium n (%) 17 (45.9) 11 (55.0)
Anticonvulsants, n (%) 23 (62.2) 11 (55.0) 0.60
Antidepressants, n (%) 14 (37.8) 8 (40.0) 0.87
Antipsychotics, n (%) 14 (37.8) 6 (30.0) 0.51
Benzodiazepines, n (%) 10 (27.0) 5 (25.0) 0.87
Melatonin, n (%) 1 (2.7) 2 (10.0) 0.24
No of medications, means (SD) 2.16 (0.8) 2.10 (1.0) 0.80
HDRS-17, Hamilton Depression Rating Scale 17 items; YMRS, Young Mania 
Rating Scale; SD, standard deviation.
TaBlE 2 | Significant clusters for the picture encoding task. Cluster peak and 
local maximum is represented with x, y, z MNI coordinates and Threshold-Free 
Cluster Enhancement corrected P-values.
Task and 
Region
side Cluster 
TFCE P
Cluster 
size 
(voxels)
x y z
Picture encoding
Occipital cortex L P < 0.002 192 –58 –66 –8
L, left; MNI, Montreal Neurologic Institute; R, right; TFCE, Threshold-Free Cluster 
Enhancement.
December 2019 | Volume 10 | Article 845Frontiers in Psychiatry | www.frontiersin.org
Val66Met and Memory in BDHørlyck et al.
5
memory recall, r(68) = 0.07, P = 0.56. There was also no statistically 
significant difference in this correlation between the ValVal (r = 
-0.07, P = 0.65) and the Met carrier (r = 0.05, P = 0.80) groups, Z = 
-0.47, P = 0.64. In the dPFC, there was no statistically significant 
correlation between memory recall and mean % signal change, 
r(68) = 0.10, P = 0.42, although when comparing the correlations 
for the two genotypes, these were significantly different, Z = 2.33, 
P = 0.02, which was due to a positive correlation between mean % 
signal change in the dPFC and memory for ValVal [r(42) = 0.29, P = 
0.06], while this correlation was negative for Met carriers, r(24) = 
-0.31, P  = 0.13. We also investigated the relationship between 
memory recall and the activity in the identified significant cluster 
in the occipital lobe across all subjects but this correlation was also 
non-significant rs(68) = 0.17, P = 0.17. Furthermore, there was no 
difference in correlation between activity in the significant cluster 
and memory recall between the two groups, Z = 0.65, P = 0.51.
Behavioral analyses
Picture recall after the scan: An independent samples t-test 
carried out on the square root-transformed data showed that 
unexpectedly, Met carriers displayed a superior picture memory 
performance (higher number of correctly recalled pictures) in 
comparison with Val homozygotes [mean ± SD, Met carriers: 
10.3 ± 5.0, Val homozygotes: 8.0 ± 5.3; t(67) = 2.35, P = 0.02, d = 
0.61; Figure 3]. There were no differences between the two groups 
in the number of false positives (i.e., “made up” pictures) (U = 
437.0, P = 0.71, η2 = 0.002). There were no significant correlations 
between picture recall and sub-syndromal mania or depression 
symptoms, age, and years of education in either of the two groups 
or across the entire sample (P ≥ 0.20). Use of antidepressants, 
lithium, anticonvulsants, antipsychotics, and diazepines was not 
associated with memory recall (P ≥ 0.13). There was no significant 
interaction effect between val66met BDNF genotype and total 
number of medications on memory recall (P = 0.23). The main 
effect of medication was also non-significant (P = 0.27).
associations Between Mood, Medication 
and BOlD Response
To investigate whether associations with mood or medication 
status could explain our obtained fMRI results, we carried out 
the following analyses: Across the entire sample, subsyndromal 
depression symptoms showed a negative correlation with mean 
% signal change in the bilateral hippocampus (HDRS; r = -0.25, 
P = 0.04). This effect was due to a strong relationship between 
HDRS scores and hippocampal activity within the ValVal group 
(r = -0.49, P < 0.001), while there was no significant relationship 
between HDRS scores and hippocampal activity in the Met 
carrier group alone (r = 0.28, P = 0.17). For the dPFC and the 
identified cluster in the LO cortex, there were no significant 
relationships between mean % signal change in these regions 
during encoding and HDRS or YMRS scores across the entire 
sample (P’s > 0.20) or within the genotype groups (P’s > 0.19).
Use of antidepressants, lithium, anticonvulsants, antipsychotics, 
and diazepines was not associated with mean percent BOLD signal 
change in the hippocampal or dPFC ROIs or in the identified LO 
cortex cluster (P’s ≥ 0.05). Assessing the effects of the total number 
of medications on neural activity during encoding, there was no 
FIgURE 2 | Encoding activity during encoding across all participating 
remitted patients with bipolar disorder, showing activity in a large network 
(marked in green). Cluster shows encoding activity for ValMet/MetMet > 
ValVal (-56 -64 -10). Effects displayed on an MNI template and thresholded at 
P > 0.05 (TFCE whole-brain). Error bars show SE. Plot shows mean percent 
blood-oxygen dependent (BOLD) signal change during encoding within the 
significant cluster. Error bars show standard error (SE).
FIgURE 3 | Mean memory score on the picture memory task for the ValVal 
and the ValMet/MetMet groups in remitted patients with bipolar disorder. 
Error bars represent SE. Significance of asterisk is at the 0.05 level (exact 
p-value is P = 0.02).
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significant interaction between val66met BDNF genotype and total 
number of medications for encoding-related activity in the dPFC or 
hippocampal ROIs, or in the identified LO cortex cluster (P > 0.05).
sensitivity analyses
To rule out the effects of subsyndromal symptoms in the current 
analyses, we conducted a sensitivity analysis only including the 
participants in full remission (HDRS < 7; YMRS < 7), yielding a 
total of 34 datasets for analysis.
Like in the full dataset, participants that were carriers of the 
Met allele showed numerically better memory performance (M = 
10.17, SD = 4.51) compared to ValVal homozygotes (M = 7.62, 
SD = 4.40), although this effect did not reach significance for this 
subset of participants, t(31) = 1.59, P = 0.12. Consistent with the 
analyses conducted on all participants, for fMRI analyses, there 
was no significant effect of genotype on activity during encoding 
in the bilateral hippocampal ROI or the dPFC. An exploratory 
whole-brain analysis did also not show any significant effect of 
genotype on activity during encoding.
DIsCUssION
We investigated for the first time the effects of BDNF Val66Met 
genotype on encoding-related hippocampal response and 
memory performance in partially or fully remitted patients 
with BD. In contrast to our hypothesis, we found no impact of 
this BDNF genotype on hippocampal (or dorsal PFC response) 
during picture encoding. However, an exploratory whole-brain 
analysis showed that Met carriers displayed greater encoding-
related neural activity in the LO cortex compared to ValVal 
homozygotes. At a behavioral level, Met carriers also displayed 
superior picture recall following the encoding session in the 
scanner compared to the ValVal homozygotes.
The lack of an association between BDNF genotype and 
hippocampal activity during encoding is in accordance with a 
previous study on healthy volunteers using an identical picture 
encoding task (6) but contrasts with other similar studies 
showing either no difference (9) or increased (8) MTL activity 
during encoding of complex scenes in healthy subjects. The lack 
of a healthy control group in this study to serve as a baseline 
challenges the interpretation of the current findings in relation 
to existing studies in healthy volunteers and hence comprises 
a limitation of the current study. Nevertheless, investigating 
the relationship between BDNF genotype, memory, and 
neural mechanisms in BD alone can still be used to identify 
potential mechanisms underlying the heterogeneity in cognitive 
impairment across BD patients. In this context, our results do 
not suggest that differences in hippocampal processing during 
memory encoding between Met carriers and ValVal homozygotes 
contribute to cognitive heterogeneity in BD.
In the exploratory whole-brain analysis, we observed an 
effect of BDNF Val66Met genotype on neural processing in 
a cluster located to the LO cortex, with Met carriers showing 
greater activity during encoding in this region compared to 
ValVal homozygotes, indicating a potential difference in visual 
processing that is dependent on genotype. The lateral occipital 
cortex is known to be involved in visual processing and object 
perception and recognition (38) and has specifically been 
implicated in identifying object shapes (39). Why encoding-
related processing in this area should be greater in Met carriers 
than ValVal homozygotes is not clear, but this finding is consistent 
with the observed better memory recall in the Met carrier group, 
although we did not observe a significant relationship between 
the mean percent BOLD signal change extracted from the 
identified cluster and subsequent memory performance.
Surprisingly, we observed better picture recall in BD Met 
carriers than in ValVal homozygotes. This was in contrast to 
our hypothesis that Met carriers would show reduced memory 
performance and also contradicts the majority of studies 
reporting a relationship between BDNF genotype and memory 
performance, where higher Met load is often associated with 
poorer memory in both healthy volunteers (9, 11, 12) and BD 
(14, 40). In terms of comparison with results from studies using 
healthy volunteers, we expected that potential effects of Val66Met 
BDNF genotype would be exacerbated in BD. However, it 
is possible that residual BD symptoms might instead blunt 
potential differences due to BDNF genotype. Another possibility 
is that different methods of memory assessment explain the 
divergent findings; we used a free recall task of complex scenes 
whereas others investigating the relationship between BDNF 
genotype and memory in BD have used other tasks such as the 
CVLT (41, 42). Hence, it is possible that subtle differences in 
the mechanisms supporting different memory types might have 
played a role in the divergent findings, where Met carriers may be 
impaired compared to ValVal homozygotes on a verbal learning 
task but not a visual learning task, which is consistent with our 
finding showing increased activity during encoding in the LO 
cortex known to play a role in visual processing.
Also, some studies have suggested that there might be a 
possible advantage of Met carriers in terms of PFC function 
and working memory (22). Free recall is dependent on both 
PFC processing and working memory function and we did see 
a significant positive correlation between dPFC activity during 
encoding and subsequent memory for the Met carrier group that 
was not present in the ValVal group. Hence, it is possible that Met 
carriers more efficiently recruited the dPFC during encoding.
Another point is that the previous studies showing better 
performance for ValVal homozygotes compared to Met carriers 
in psychiatric populations have often used samples including 
both remitted and currently depressed patients (e.g. 15). Such 
samples may show reduced performance on cognitive tasks due 
to patients’ affective symptoms (43), which might interact with 
Met load. A strength of the current study was the inclusion of a 
relatively homogeneous sample of remitted or partially remitted 
BD patients, which limited confounding effects of affective 
symptoms compared to previous studies. However, this study did 
include patients in both partial and full remission, and hence, 
sub-syndromal mood symptoms could have had an impact on 
memory performance in this study too. In this context, we found 
a negative correlation between residual depression symptoms 
and hippocampal activity during encoding across the entire 
sample, suggesting that patients with more depressive symptoms 
recruited the hippocampus less efficiently during learning. This 
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observation is consistent with the state-related impairments 
in learning and memory seen in depression. Interestingly, this 
association was more pronounced in the ValVal homozygotes 
who are believed to have more activity-dependent hippocampal 
BDNF trafficking and greater encoding-related hippocampal 
response when healthy (9).
To further address the potential significance of residual 
depressive symptoms, we carried out sensitivity analyses only 
including patients in full remission and consistent with the main 
analyses, we found no significant effect of genotype on activity 
during encoding in the predefined dPFC or hippocampal ROIs. 
For the sensitivity analyses, the whole-brain analyses did not 
yield any significant effect of genotype. However it should be 
noted that the sample size was dramatically reduced in these 
analyses (N = 33).
For the main analyses, we used a relatively large sample size 
(N = 68) for assessment of differences between the genotype 
groups in encoding-related neural activity. In comparison, other 
studies used between 22 and 58 participants (6, 8, 9, 14, 42). Due 
to a small number of participants with the MetMet genotype 
(N = 4), we decided to not compare patients with the MetMet and 
ValMet genotypes. We were thus unable to explore a potential 
association between Met load and clinical, cognitive and neural 
responses as done in previous studies (6, 44). Indeed, this could 
have brought more clarity to the current results showing a weak 
advantage for Met-carriers on the free recall task. Further, as 
all participants received psychotropic medication it cannot be 
excluded that this has influenced the present result. Finally, as 
mentioned previously, having a healthy control group to serve as 
a baseline and comparison with previous studies using healthy 
subjects would have been an advantage.
In conclusion, we found no association between BDNF 
val66met genotype and hippocampal or dorsal PFC activity 
during picture encoding, although Met carriers showed an 
unexpected greater picture recall after the scan. Exploratory 
whole-brain analysis revealed larger lateral occipital cortex 
response in Met carriers, which might reflect increased visual 
processing during picture encoding in this group, although 
activity in this region did not correlate with subsequent memory 
performance. Instead, Met carriers might show more efficient 
processing in the dPFC during encoding compared to ValVal 
carriers. The absence of effects of BDNF val66met genotype on 
memory-related hippocampal response in our BD sample may 
be due to the effects of subsyndromal symptoms overriding 
more subtle effects of BDNF val66met genotype since we 
allowed subsyndromal symptoms in our sample in the interest 
of generalizability. Specifically, future studies should use even 
larger samples (n > 70), include a healthy control group, and 
investigate fully remitted BD patients (with scores <7 on HDRS 
and YMRS) or healthy, non-medicated participants at high risk 
for BD (first-degree relatives) to assess potential dose-dependent 
effects of Met load on neural and cognitive measures of learning 
and memory in BD.
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